Germany· DE-A57-a37548d1b0973f19
Schlaf- Und Nerventee N
A medicinal product containing peppermint leaf, valeriana officinalis l. radix, melissa officinalis l. folium, passiflora incarnata l. herba, registered in Germany by Bombastus-Werke Ag.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Peppermint Leaf, Valeriana Officinalis L. Radix, Melissa Officinalis L. Folium, Passiflora Incarnata L. Herba
- Manufacturer
- Bombastus-Werke Ag
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/beb471e3-ac53-42b4-8dff-64a3aa083b42 GET /v1/drugs/beb471e3-ac53-42b4-8dff-64a3aa083b42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Peppermint Leaf, Valeriana Officinalis L. Radix, Melissa Officinalis L. Folium, Passiflora Incarnata L. Herba",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about peppermint leaf, valeriana officinalis l. radix, melissa officinalis l. folium, passiflora incarnata l. herba.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.